JP Stock MarketDetailed Quotes

4527 Rohto Pharmaceutical

Watchlist
  • 2719.0
  • +31.5+1.17%
20min DelayNot Open Dec 20 15:30 JST
642.17BMarket Cap20.11P/E (Static)

Rohto Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Total revenue
11.75%68.36B
13.48%270.84B
11.66%69.68B
11.14%73.29B
14.88%66.7B
17.06%61.17B
19.54%238.66B
12.18%62.4B
24.43%65.95B
19.21%58.06B
Cost of revenue
15.28%29.28B
12.16%113.55B
12.86%29.81B
10.52%29.83B
13.25%28.51B
12.09%25.4B
21.28%101.24B
13.93%26.42B
24.51%27B
23.27%25.17B
Gross profit
9.24%39.08B
14.45%157.29B
10.78%39.87B
11.56%43.46B
16.13%38.19B
20.87%35.77B
18.29%137.42B
10.93%35.99B
24.37%38.96B
16.28%32.89B
Operating expense
11.46%27.29B
13.32%117.23B
14.56%35.08B
9.53%29.16B
14.46%28.51B
14.93%24.48B
18.71%103.46B
14.39%30.62B
22.54%26.63B
21.19%24.91B
Staff costs
----
7.52%22.01B
----
----
----
----
11.37%20.47B
----
----
----
Selling and administrative expenses
----
16.68%54.22B
----
----
----
----
21.92%46.47B
----
----
----
-Selling and marketing expense
----
16.68%54.22B
----
----
----
----
21.92%46.47B
----
----
----
Research and development costs
----
21.01%13.39B
----
----
----
----
26.60%11.07B
----
----
----
Depreciation and amortization
----
3.59%2.42B
----
----
----
----
10.70%2.34B
----
----
----
-Depreciation
----
1.58%1.99B
----
----
----
----
18.12%1.96B
----
----
----
-Amortization
----
13.84%436M
----
----
----
----
-16.19%383M
----
----
----
Other operating expenses
----
8.98%25.19B
----
----
----
----
16.73%23.12B
----
----
----
Operating profit
4.41%11.79B
17.92%40.05B
-10.75%4.79B
15.95%14.3B
21.33%9.67B
36.13%11.29B
17.04%33.96B
-5.41%5.37B
28.51%12.33B
3.20%7.97B
Net non-operating interest income (expenses)
38.52%374M
85.59%1.33B
54.89%412M
150.35%353M
160.71%292M
37.76%270M
495.83%715M
818.92%266M
138.98%141M
100.00%112M
Non-operating interest income
38.92%439M
58.32%1.52B
34.17%428M
100.00%424M
99.44%355M
24.90%316M
161.41%962M
243.01%319M
103.85%212M
83.51%178M
Non-operating interest expense
41.30%65M
-20.65%196M
-69.81%16M
0.00%71M
-4.55%63M
-19.30%46M
-0.40%247M
-59.23%53M
57.78%71M
60.98%66M
Net investment income
12.45%289M
15.19%933M
28.97%463M
3.99%-265M
1.27%478M
0.78%257M
111.49%810M
232.96%359M
-263.31%-276M
9,340.00%472M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
-187.01%-221M
-274.18%-1.01B
-129.18%-164M
-4,120.00%-603M
53.33%-161M
-122.32%-77M
172.31%577M
345.41%562M
103.23%15M
-56.82%-345M
Income from associates and other participating interests
-98.65%1M
-259.67%-289M
-1,067.57%-358M
-121.25%-17M
-14.29%12M
48.00%74M
26.57%181M
5.71%37M
-54.02%80M
193.33%14M
Special income (charges)
-157.72%-142M
0
0
0
29.91%-246M
2,833.33%246M
-24.49%-1.54B
-63.95%-1.39B
238.93%207M
-715.79%-351M
Less:Other special charges
---23M
----
----
----
----
----
219.53%153M
--0
--0
----
Less:Write off
167.07%165M
--0
----
----
24.24%246M
-2,833.33%-246M
-32.34%1.39B
----
----
-68.47%198M
Other non-operating income (expenses)
-98.89%2M
222.28%505M
56.22%-190M
133.67%263M
-12.50%252M
-64.98%180M
-267.89%-413M
-734.62%-434M
-642.36%-781M
700.00%288M
Income before tax
-1.21%12.09B
21.08%41.52B
3.88%4.95B
19.71%14.03B
26.23%10.3B
26.87%12.24B
23.02%34.29B
11.49%4.76B
22.99%11.72B
6.74%8.16B
Income tax
20.70%3.61B
28.79%10.12B
-50.00%84M
36.45%4.32B
40.74%2.73B
15.58%2.99B
17.56%7.86B
-46.15%168M
-5.55%3.17B
42.47%1.94B
Net income
-8.30%8.48B
18.79%31.39B
5.88%4.86B
13.49%9.71B
21.70%7.57B
31.03%9.25B
24.74%26.43B
15.98%4.59B
38.49%8.55B
-0.99%6.22B
Net income continuous operations
-8.29%8.49B
18.79%31.4B
5.85%4.86B
13.51%9.71B
21.71%7.57B
31.01%9.25B
24.74%26.43B
16.04%4.6B
38.48%8.55B
-1.00%6.22B
Noncontrolling interests
-99.38%1M
778.85%457M
158.62%85M
34.91%143M
209.09%68M
133.33%161M
-13.33%52M
-154.39%-145M
21.84%106M
100.00%22M
Net income attributable to the company
-6.69%8.48B
17.28%30.94B
0.82%4.78B
13.24%9.56B
21.01%7.5B
30.02%9.09B
24.85%26.38B
18.00%4.74B
38.72%8.45B
-1.15%6.2B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-6.69%8.48B
17.28%30.94B
0.82%4.78B
13.24%9.56B
21.01%7.5B
30.02%9.09B
24.85%26.38B
18.00%4.74B
38.72%8.45B
-1.15%6.2B
Gross dividend payment
Basic earnings per share
-6.70%37.18
17.29%135.61
0.82%20.95
13.27%41.92
21.01%32.89
30.02%39.85
24.85%115.62
18.00%20.78
38.69%37.01
-1.15%27.18
Diluted earnings per share
-6.67%37.08
17.28%135.21
0.77%20.88
13.25%41.8
21.03%32.8
30.01%39.73
24.85%115.29
18.00%20.72
38.73%36.91
-1.15%27.1
Dividend per share
0
22.73%27
25.00%15
0
20.00%12
0
22.22%22
14.29%12
0
33.33%10
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Total revenue 11.75%68.36B13.48%270.84B11.66%69.68B11.14%73.29B14.88%66.7B17.06%61.17B19.54%238.66B12.18%62.4B24.43%65.95B19.21%58.06B
Cost of revenue 15.28%29.28B12.16%113.55B12.86%29.81B10.52%29.83B13.25%28.51B12.09%25.4B21.28%101.24B13.93%26.42B24.51%27B23.27%25.17B
Gross profit 9.24%39.08B14.45%157.29B10.78%39.87B11.56%43.46B16.13%38.19B20.87%35.77B18.29%137.42B10.93%35.99B24.37%38.96B16.28%32.89B
Operating expense 11.46%27.29B13.32%117.23B14.56%35.08B9.53%29.16B14.46%28.51B14.93%24.48B18.71%103.46B14.39%30.62B22.54%26.63B21.19%24.91B
Staff costs ----7.52%22.01B----------------11.37%20.47B------------
Selling and administrative expenses ----16.68%54.22B----------------21.92%46.47B------------
-Selling and marketing expense ----16.68%54.22B----------------21.92%46.47B------------
Research and development costs ----21.01%13.39B----------------26.60%11.07B------------
Depreciation and amortization ----3.59%2.42B----------------10.70%2.34B------------
-Depreciation ----1.58%1.99B----------------18.12%1.96B------------
-Amortization ----13.84%436M-----------------16.19%383M------------
Other operating expenses ----8.98%25.19B----------------16.73%23.12B------------
Operating profit 4.41%11.79B17.92%40.05B-10.75%4.79B15.95%14.3B21.33%9.67B36.13%11.29B17.04%33.96B-5.41%5.37B28.51%12.33B3.20%7.97B
Net non-operating interest income (expenses) 38.52%374M85.59%1.33B54.89%412M150.35%353M160.71%292M37.76%270M495.83%715M818.92%266M138.98%141M100.00%112M
Non-operating interest income 38.92%439M58.32%1.52B34.17%428M100.00%424M99.44%355M24.90%316M161.41%962M243.01%319M103.85%212M83.51%178M
Non-operating interest expense 41.30%65M-20.65%196M-69.81%16M0.00%71M-4.55%63M-19.30%46M-0.40%247M-59.23%53M57.78%71M60.98%66M
Net investment income 12.45%289M15.19%933M28.97%463M3.99%-265M1.27%478M0.78%257M111.49%810M232.96%359M-263.31%-276M9,340.00%472M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets -187.01%-221M-274.18%-1.01B-129.18%-164M-4,120.00%-603M53.33%-161M-122.32%-77M172.31%577M345.41%562M103.23%15M-56.82%-345M
Income from associates and other participating interests -98.65%1M-259.67%-289M-1,067.57%-358M-121.25%-17M-14.29%12M48.00%74M26.57%181M5.71%37M-54.02%80M193.33%14M
Special income (charges) -157.72%-142M00029.91%-246M2,833.33%246M-24.49%-1.54B-63.95%-1.39B238.93%207M-715.79%-351M
Less:Other special charges ---23M--------------------219.53%153M--0--0----
Less:Write off 167.07%165M--0--------24.24%246M-2,833.33%-246M-32.34%1.39B---------68.47%198M
Other non-operating income (expenses) -98.89%2M222.28%505M56.22%-190M133.67%263M-12.50%252M-64.98%180M-267.89%-413M-734.62%-434M-642.36%-781M700.00%288M
Income before tax -1.21%12.09B21.08%41.52B3.88%4.95B19.71%14.03B26.23%10.3B26.87%12.24B23.02%34.29B11.49%4.76B22.99%11.72B6.74%8.16B
Income tax 20.70%3.61B28.79%10.12B-50.00%84M36.45%4.32B40.74%2.73B15.58%2.99B17.56%7.86B-46.15%168M-5.55%3.17B42.47%1.94B
Net income -8.30%8.48B18.79%31.39B5.88%4.86B13.49%9.71B21.70%7.57B31.03%9.25B24.74%26.43B15.98%4.59B38.49%8.55B-0.99%6.22B
Net income continuous operations -8.29%8.49B18.79%31.4B5.85%4.86B13.51%9.71B21.71%7.57B31.01%9.25B24.74%26.43B16.04%4.6B38.48%8.55B-1.00%6.22B
Noncontrolling interests -99.38%1M778.85%457M158.62%85M34.91%143M209.09%68M133.33%161M-13.33%52M-154.39%-145M21.84%106M100.00%22M
Net income attributable to the company -6.69%8.48B17.28%30.94B0.82%4.78B13.24%9.56B21.01%7.5B30.02%9.09B24.85%26.38B18.00%4.74B38.72%8.45B-1.15%6.2B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -6.69%8.48B17.28%30.94B0.82%4.78B13.24%9.56B21.01%7.5B30.02%9.09B24.85%26.38B18.00%4.74B38.72%8.45B-1.15%6.2B
Gross dividend payment
Basic earnings per share -6.70%37.1817.29%135.610.82%20.9513.27%41.9221.01%32.8930.02%39.8524.85%115.6218.00%20.7838.69%37.01-1.15%27.18
Diluted earnings per share -6.67%37.0817.28%135.210.77%20.8813.25%41.821.03%32.830.01%39.7324.85%115.2918.00%20.7238.73%36.91-1.15%27.1
Dividend per share 022.73%2725.00%15020.00%12022.22%2214.29%12033.33%10
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
Wintest
6721
127 +30.93%
Showcase
3909
349 +29.74%
Beauty Kadan Holdings
3041
417 +23.74%
Cybozu
4776
2644 +23.32%
KODAMA CHEMICAL INDUSTRY
4222
440 +22.22%

See the daily top gainer.